Abstract: Efficient ways to identify children with HIV in the context of universal test-and-treat policies are needed. We evaluated a hybrid testing strategy combining mobile community and home-based HIV testing in 87,700 children across 32 rural communities in 2 East African countries. This approach resulted in 81% testing coverage of at-risk children and doubled the number of children diagnosed with HIV.
D
espite global expansion of testing and treatment programs, children in eastern and southern Africa accounted for 9.7% (77,000/790,000) of the new HIV infections and 14% (58,000/420,000) of AIDS-related deaths in the region in 2016. 1 Early infant diagnosis (EID) programs represent the primary method of achieving early HIV diagnosis of at-risk children, but large portions of children are often lost to follow-up after the first test. 2 Additional methods to diagnose children with HIV are needed to enable immediate treatment and prevent mortality.
The Sustainable East Africa Research in Community Health trial (SEARCH: NCT01864603) achieved HIV testing coverage of 89% for adults (≥15 years old) 3 and 86% for adolescents (10-14 years old) 4 in 32 communities of rural Uganda and Kenya during the trial's baseline year, by incorporating HIV testing into a hybrid out-of-facility testing strategy of multidisease mobile community health campaigns (CHCs) followed by home-based HIV testing of campaign nonattendees. We conducted a subanalysis within the SEARCH study to evaluate the effectiveness of the hybrid testing program in achieving population-level HIV testing coverage among children, 2-9 years old, and examined predictors of children not testing.
METHODS
Between April 2013 and June 2014, the SEARCH trial enumerated and collected demographic information on residents of 32 rural communities each comprising approximately 10,000 individuals in western Kenya and eastern and southwestern Uganda. 3 Following the census, staff implemented 2-week multidisease CHCs in partnership with the local health authorities in each community. Rapid finger-prick blood-based HIV antibody test kits, and serial rapid HIV antibody testing algorithms following local guidelines were used to test all children ≥18 months old for HIV infection, with Determine HIV-1/2 Rapid Test followed by Unigold for confirmation. In addition to HIV testing, CHCs offered deworming, malaria screening and Vitamin A supplementation. Following CHC completion, children who were considered "at-risk" for HIV infection, defined as having a mother with positive or unknown HIV serostatus, and did not attend the CHCs (identified using census data), were physically tracked for home-based HIV testing (HBT). A mother's serostatus could be unknown because the mother was deceased, moved away, declined testing or was unable to be linked to the child based on relationship information obtained at enumeration.
We included stable resident (reported living in study community for ≥6 months in the year prior) children 2-9 years old. We evaluated testing coverage of all enumerated children and coverage of the at-risk subgroup. We additionally examined predictors for nontesting among at-risk children using generalized estimating equations modeling with an exchangeable working correlation structure, including region as a fixed effect and clustering on household. We also report the yield of positive HIV tests by this hybrid approach, and the proportion of infected children reporting no prior testing.
RESULTS
Among 92,030 children 2-9 years of age enumerated via census in the 32 SEARCH communities, 87,700 (95%) were stable residents. Maternal serostatus was negative for 66% (57,655/87,700) of children, positive for 8% (7055/87,700) and unknown in 26% (22,990/87,700); 34% (30,045/87,700) of children were thus considered at-risk. Among children with unknown maternal status (n = 22,990), reasons identified were insufficient information to link children to mothers (70%; n = 16,186), mother not tested at CHC or HBT (11%, n = 2535), mother declined testing (10%; n = 2208), mother deceased (8%; n = 1897) or testing assay error (1%; n = 164).
Among the 87,700 stable resident children, 76% (66,421) were tested for HIV during the CHC and 7% (5820) were tested by HBT, achieving total population testing coverage of 82% (72,241/87,700). Among the at-risk subset of children, HIV testing coverage was 81% (24,414/30,045) across the 3 regions (Table 1) . Of these, 84% (20,580/24,414) were tested at CHC and 16% (3834/24,414) at HBT. The reasons for 5631 at-risk children not being tested were as follows: 31% (n = 1761) attended CHC but declined HIV testing, 25% (n = 1401) tracked but not found for HBT, 22% (n = 1271) tracked for HBT but declined participation and 21% (n = 1198) tracked for HBT but not tested for undocumented reasons. Among at-risk children, significant risk factors for not testing were residence in Kenya [adjusted Odds Ratio (aOR), 3 A total of 817 of the 72,241(1.1%) children tested through this hybrid testing strategy were identified as HIV infected. The yield of testing differed by region, with 2.6% (585/22,267) testing positive in Kenya compared with 0.4% (102/27,876) in East Uganda and 0.6% (130/22,098) in Southwest Uganda ( Table 1) . The median CD4 count among children with HIV was 1009 cells/ mm 3 (interquartile range, 676-1378). Most children with HIV, 59% (483/817), were linked to mothers who tested positive for HIV, but 33% (273/817) had unknown maternal HIV status and 7% (61/817) were reported to be children of women who had tested negative. Among children of deceased mothers, the testing yield was 5% (92/1897); 34% (92/237) of children with unknown maternal status had deceased mothers. Among children who tested positive for HIV, 45% (367/817) had parents/guardians who reported the child had no prior positive HIV test.
DISCUSSION
The SEARCH community-based hybrid mobile testing model achieved high population-level coverage of 82% among all children 2-9 years old, including 81% of at-risk children, during the baseline year of the trial. These high rates of population testing coverage among children were feasible by integrating pediatric HIV testing into large-scale CHC testing, combined with targeted homebased testing of at-risk children based on maternal HIV status for CHC nonattendees. While the overall yield was only 1.1% among 72,241 tests, significant efficiency was gained by integration into the larger campaign that also provided other health services to adults and children, including hypertension, diabetes and cervical cancer screening, male circumcision, child immunization and Vitamin A supplementation.
Current EID programs have had limited success in testing at-risk children. An evaluation of 24 Ugandan health facilities in 2012 showed that less than 26% of HIV-exposed infants completed the EID testing algorithm.
2 EID programs in Kenya have shown improvement over time, with a decline in losses to follow-up, from 15% in 2011 to 8% in 2013; 5 however, this means many children not being tested after their exposure to transmission from breastfeeding. New recommendations to test at birth and expanded availability of rapid turn-around nucleic acid testing assays may increase the efficacy of EID programs. However, even without any loss to follow-up, EID programs suffer an inherent limitation in reaching all HIV-exposed infants. By relying on testing of women in prenatal care or labor clinics, EID programs systematically miss infants of women who fail to engage in antenatal care, deliver at home or transmit infection during lactation following intra-or postpartum seroconversion.
Efficient ways to test children beyond infancy and breastfeeding will be required for countries attempting to achieve The Joint United Nations Programme on HIV and AIDS (UNAIDS) goal of identifying 90% of HIV-infected children. 6 Targeted testing of ill children is one approach; up to 29% of children being treated for malnutrition and 22% of children with Tuberculosis (TB) also have HIV infection. 7 A major limitation of these approaches is that they identify children only after disease has progressed; the high median CD4 count of children diagnosed with HIV suggests that some may have been early in disease progression, though some may also have already been on therapy (data not collected). Our results also underscore the limitations of testing approaches that only target children of known seropositive women: 40% of the infected children in our study had not been identified to be children of infected women, and 7% had been reported to be children of seronegative women. This demonstrates that patient/parent reported information cannot be considered perfectly accurate; testing programs aiming to reach 100% of at-risk children are likely going to need to include multiple approaches, including targeting children through family/adult HIV treatment clinics. 
